Today: 27 June 2026
Prudential stock price today: PRU shares lift on buyback update as results near
23 February 2026
1 min read

Prudential stock price today: PRU shares lift on buyback update as results near

London, Feb 23, 2026, 09:36 GMT — Regular session underway

  • Prudential shares gained roughly 0.9% in early trading in London.
  • The insurer reported purchasing 250,585 shares on Feb. 20 for cancellation.
  • Prudential’s full-year numbers land in March, and investors are already watching closely.

Shares in Prudential plc ticked up 0.9% to 1,143.5 pence on Monday, following news of fresh share buybacks by the insurer with a strong Asia footprint. The stock moved within a range of 1,134 to 1,148 pence, after finishing last session at 1,133 pence. That’s still short of the 52-week high at 1,238 pence.

Buyback announcements trickle out in modest amounts, but they have a knack for keeping capital returns in the spotlight right when investors are gearing up for the next round of results. For Prudential, timing is everything—its shares have a habit of moving with shifts in risk appetite, both for Asia and the insurance sector at large.

Here’s the gist of a share buyback: the company steps into the market, repurchases its own stock, and then cancels those shares, trimming down the total share count. With fewer shares on the table, per-share figures often get a boost—regardless of whether the core business shifts much any time soon.

Prudential snapped up 250,585 ordinary shares via JP Morgan Securities on Feb. 20, shelling out an average of 11.3285 pounds apiece. The company intends to cancel these shares, bringing its total ordinary shares outstanding to 2,536,912,507 after the buyback.

Prudential’s $1.2 billion buyback, announced for 2026, breaks down into $500 million in recurring capital returns and $700 million sourced from net proceeds related to the ICICI Prudential Asset Management IPO. Management noted that how quickly and when the program moves forward will hinge on both market conditions and execution factors.

Action was choppy outside the major indexes. Fresh U.S. trade policy headlines sent investors scrambling for safety in early European hours, with the FTSE 100 slipping modestly. “The tariff landscape is now more uncertain than before,” wrote Rodrigo Catril, senior FX strategist at NAB, in a Reuters note. Reuters

Currency remains an underlying factor for Prudential investors. While consolidated financials come out in U.S. dollars and dividends are approved in dollars, UK shareholders generally get paid in sterling unless they choose something different, according to the company.

But buybacks won’t protect stocks if volatility jumps again. A deeper equity selloff, shakier sentiment on Asia’s growth outlook, or sudden currency moves could weigh on shares more than any gradual cut in share count.

The nearest major marker for investors is Prudential’s 2025 full-year results, slated for March 18. After that, the company plans to give a business performance update for the three months through March 31 on April 30, per its financial calendar.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • ON Semiconductor (ON) Stock Falls 25% in a Week; Valuation Perspectives Analyzed
    June 27, 2026, 2:40 PM EDT. ON Semiconductor shares dropped 25.5% last week to close at $90.65, despite a 59.9% gain year-to-date. The stock is down 27.4% over a month but remains up over 70% in the past year. Market reassessments reflect changing expectations around electric vehicles, power management, and chip supply industry dynamics. A Discounted Cash Flow (DCF) analysis indicates the stock is overvalued by about 27%, assigning a fair value of $71.39 versus the current price, suggesting a premium on cash flow forecasts. The company holds a 3 out of 6 valuation score under Simply Wall St's framework. Investors should consider multiple valuation methods and sector trends before concluding if ON Semiconductor's dip presents an attractive entry point.

Latest articles

Coca-Cola (NYSE:KO) stock run brings IRS $20 billion case into view for investors

Coca-Cola (NYSE:KO) stock run brings IRS $20 billion case into view for investors

27 June 2026
Coca-Cola (KO) surged 2.75% to $82.63 Friday, outpacing staples as a federal appeals court appeared receptive to KO’s arguments in its $14 billion IRS tax dispute; the stock’s $3.24 gain since June 18 was driven mostly by Friday’s $2.21 jump, with analysts noting the case’s outcome could impact billions in potential refunds or liabilities.
Fiserv (NASDAQ:FISV) sees stock lift after CEO surprise

Fiserv (NASDAQ:FISV) sees stock lift after CEO surprise

27 June 2026
Fiserv jumped 4.8% for the week, defying market declines after insider buys clustered around $49–$51 and a CEO change; heavy Friday trading set the $49–$50 level as a key test for investor confidence in the shortened trading week, with the stock closing at $49.45—just below the insiders’ average purchase price.
Eaton (NYSE:ETN) resets as $13 billion loss hits targets

Eaton (NYSE:ETN) resets as $13 billion loss hits targets

27 June 2026
Eaton (NYSE:ETN) plunged 7.6% in five sessions—wiping out $13.2 billion in equity value and closing 7.8% below its June 22 high—on heavy volume, as investors weighed its premium valuation at 30 times 2026 EPS estimates and awaited the next earnings report amid strong data-center order growth and a major mobility unit spinoff.
GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines
Previous Story

GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop